Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Reliability and Validity01:29

Reliability and Validity

14.1K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
14.1K
Data Validation01:15

Data Validation

2.2K
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
2.2K
Data Validation01:03

Data Validation

6.9K
Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.9K
Formulating and Validating Nursing Diagnosis I01:26

Formulating and Validating Nursing Diagnosis I

4.0K
A nursing diagnosis is written when the nurse recognizes a cluster of essential patient data indicating health problems treated with independent nursing interventions. The standardized terminologies of a nursing diagnosis help nurses identify and treat patients' problems. Every electronic health record that uses nursing diagnosis must employ standard diagnostic terminology. Developing an efficient, individualized care plan begins with accurate nursing diagnoses.
There are thirteen domains...
4.0K
Formulating and Validating Nursing Diagnosis II01:25

Formulating and Validating Nursing Diagnosis II

4.0K
Nursing diagnoses represent a problem validated by major defining characteristics. There are four categories of nursing diagnoses: problem-focused, risk, health promotion or wellness, and syndrome. The anatomy of a nursing diagnosis includes three components: problem statement or diagnostic label, defining characteristics, and related factors.
Risk nursing diagnoses represent clinical judgments of an individual, family, or community more vulnerable to developing the health problem than others...
4.0K
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

367
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
367

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Begelomab (BEGESAND<sup>®</sup>) Salvages Steroid-Resistant Acute GVHD in Pediatric Patients.

Journal of clinical medicine·2026
Same authorSame journal

HER2 In Situ Hybridization: Validation and Implementation of Brightfield Assay in a US Academic Pathology Laboratory.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same author

Nodular lymphocyte-predominant Hodgkin lymphoma controversy and insights: a global NLPHL one working group summit report.

Leukemia·2026
Same author

Utility of ultrasensitive, US Food and Drug Administration-approved κ and λ dual in situ hybridization assay in the diagnosis of Hodgkin lymphomas.

American journal of clinical pathology·2026
Same author

Peripheral Nerve Infiltration by CAR T-cells in a Case of Mononeuritis Multiplex after Ciltacabtagene Autoleucel.

Blood cell therapy·2026
Same author

Reporting of both positive and negative concordance is necessary to recognise and investigate bias in digital algorithms.

Journal of clinical pathology·2026
Same journal

ISIMM Page.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Clinicopathologic Features of Warthin-Like Subtype of Papillary Thyroid Carcinoma.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Keratoameloblastoma of the Jaw Bones: Description of 2 Rare Cases and Cytokeratin Profile.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Role of Twist and Vimentin as Epithelial-Mesenchymal Transition Biomarkers in Oral Squamous Cell Carcinoma: Relation to Cancer-Associated Fibroblasts.

Applied immunohistochemistry & molecular morphology : AIMM·2026
Same journal

Exploring the Immune Microenvironment for Predicting Immunotherapy Efficacy in Epstein-Barr Virus-Associated Gastric Cancer.

Applied immunohistochemistry & molecular morphology : AIMM·2026
See all related articles

Related Experiment Video

Updated: Feb 13, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K

Immunohistochemistry New Instrument Validations: Why Your Validation Plan Matters.

Sebastian Fernandez-Pol1, Kelly Young, Ivy Mangonon

  • 1Stanford University Medical Center.

Applied Immunohistochemistry & Molecular Morphology : AIMM
|February 11, 2026
PubMed
Summary
This summary is machine-generated.

Automated immunohistochemistry instrument validation requires a robust plan. Addressing challenges like stain variability and cold zones ensures reliable diagnostic results.

Keywords:
immunohistochemistryinstrumentquantitative image analysisvalidation

More Related Videos

Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.0K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K

Related Experiment Videos

Last Updated: Feb 13, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.6K
Assays for Validating Histone Acetyltransferase Inhibitors
09:11

Assays for Validating Histone Acetyltransferase Inhibitors

Published on: August 6, 2020

7.0K
Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.7K

Area of Science:

  • Biomedical instrumentation
  • Histopathology techniques
  • Diagnostic assay development

Background:

  • Immunohistochemistry (IHC) assay validation is regulated, but automated instrument validation lacks clear guidance.
  • New platforms and same-model instrument validation present unique challenges.
  • Existing validation protocols may not adequately address instrument-specific performance issues.

Purpose of the Study:

  • To provide insights and propose a framework for validating automated IHC instrumentation.
  • To highlight key challenges encountered during instrument validation.
  • To advocate for enhanced vendor testing and improved validation strategies.

Main Methods:

  • Documenting laboratory experiences with validating new automated IHC platforms and instruments.
  • Identifying and analyzing common issues like variability in stain intensity and "cold zones."
  • Evaluating the impact of tissue location and size on staining results.

Main Results:

  • Variability in stain intensity due to tissue location on slides was observed.
  • "Cold zones" on slides can affect stain interpretation and diagnostic accuracy.
  • A comprehensive validation plan is crucial for reliable automated IHC.

Conclusions:

  • A robust validation strategy must include diverse assay-tissue combinations and strategic tissue placement.
  • Vendors should improve instrument testing to proactively identify subtle performance issues.
  • Emerging quantitative technologies can enhance future validation approaches.